Evidence map›Paper›PMID 33919727›Full record

ArticleMaterials (Basel, Switzerland)2021

Evaluation of Drug-Loading Ability of Poly(Lactic Acid)/Hydroxyapatite Core-Shell Particles.

Seiya Suzuki, Sungho Lee, Tatsuya Miyajima, Katsuya Kato, Ayae Sugawara-Narutaki, Makoto Sakurai, Fukue Nagata

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Seiya SuzukiNational Institute of Advanced Industrial Science and Technology (AIST), 2266-98 Anagahora, Shimoshidami, Moriyama-ku, Nagoya 463-8560, Japan.
Sungho LeeNational Institute of Advanced Industrial Science and Technology (AIST), 2266-98 Anagahora, Shimoshidami, Moriyama-ku, Nagoya 463-8560, Japan.ORCID 0000-0002-4367-9573
Tatsuya MiyajimaNational Institute of Advanced Industrial Science and Technology (AIST), 2266-98 Anagahora, Shimoshidami, Moriyama-ku, Nagoya 463-8560, Japan.ORCID 0000-0003-3084-9112
Katsuya KatoNational Institute of Advanced Industrial Science and Technology (AIST), 2266-98 Anagahora, Shimoshidami, Moriyama-ku, Nagoya 463-8560, Japan.ORCID 0000-0001-8981-8359
Ayae Sugawara-NarutakiDepartment of Energy Engineering, Graduate School of Engineering, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8603, Japan.ORCID 0000-0003-3579-6689
Makoto SakuraiDepartment of Applied Chemistry, College of Engineering, Chubu University, Matsumoto-cho, Kasugai 487-8501, Japan.
Fukue NagataNational Institute of Advanced Industrial Science and Technology (AIST), 2266-98 Anagahora, Shimoshidami, Moriyama-ku, Nagoya 463-8560, Japan.ORCID 0000-0002-5284-9626

Funding

Japan Science and Technology Agency JPMJTS1624
6 · The paper itself

Abstract

Poly(lactic acid)/hydroxyapatite (PLA/HAp) core-shell particles are prepared using the emulsification method. These particles are safe for living organisms because they are composed of biodegradable polymers and biocompatible ceramics. These particles are approximately 50-100 nm in size, and their hydrophobic substance loading can be controlled. Hence, PLA/HAp core-shell particles are expected to be used as drug delivery carriers for hydrophobic drugs. In this work, PLA/HAp core-shell particles with a loading of vitamin K

Indexed as

core–shell particlesdrug delivery systemhydroxyapatiteloading capacitypoly(lactic acid)

Identifiers

PMID33919727
PMCPMC8070725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.